AARD
NASDAQ HealthcareAardvark Therapeutics, Inc. - Common Stock
Biotechnology
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
๐ Market Data
| Price | $6.33 |
|---|---|
| Volume | 146,685 |
| Market Cap | 138.53M |
| RSI (14-Day) | 57.9 |
| 200-Day MA | $9.07 |
| 50-Day MA | $4.87 |
| 52-Week High | $17.94 |
| 52-Week Low | $3.35 |
| Forward P/E | -1.96 |
| Price / Book | 1.59 |
๐ฏ Investment Strategy Scores
AARD scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (91/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Institutional Whale (2/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find AARD in your text
Paste any article, transcript, or post โ the tool will extract AARD and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-07-16.